Alexander K Stewart

Trials

Studies that name Alexander K Stewart as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:29 UTC. Open this list on ClinicalTrials.gov

• Ph1/Ph2
  NCT01034553 · Aurora A Kinase Inhibitor MLN8237 and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma

  Mayo Clinic · completed · Refractory Multiple Myeloma · study chair
• Ph3
  NCT00602641 · Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma

  National Cancer Institute (NCI) · active not recruiting · Multiple Myeloma · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 12:29 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.

• Project 1 - High Throughtput Drug Screening and Correlations with Mutational Status in Myeloma Cell Lines and Patient Samples
  U54CA224018 · NCI · MAYO CLINIC ARIZONA · fiscal years 2017 to 2020 · $332,666 awarded in 2020
  Same name and institution; not confirmed by an ID
• Clonal Evolution in Multiple Myeloma
  P50CA186781 · NCI · MAYO CLINIC ARIZONA · fiscal years 2015 to 2019 · $254,798 awarded in 2019
  Same name and institution; not confirmed by an ID
• The Role of Cereblon Pathways in Myeloma
  R01CA183968 · NCI · MAYO CLINIC ARIZONA · fiscal years 2014 to 2018 · $446,267 awarded in 2018
  Same name and institution; not confirmed by an ID
• Translation of Novel Therapeutic Targets in Multiple Myeloma
  R01CA167511 · NCI · MAYO CLINIC ARIZONA · fiscal years 2013 to 2017 · $431,907 awarded in 2017
  Same name and institution; not confirmed by an ID
• A Genome Wide RNAi Vulnerability Map for Myeloma
  R01CA133115 · NCI · MAYO CLINIC ARIZONA · fiscal years 2008 to 2012 · $246,800 awarded in 2012
  Same name and institution; not confirmed by an ID
• The Molecular Basis for Bortezomib Activity
  R01CA129009 · NCI · MAYO CLINIC ARIZONA · fiscal years 2007 to 2011 · $295,041 awarded in 2011
  Same name and institution; not confirmed by an ID

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• ECOG-ACRIN Network Group Operations Center
  U10CA180820 · NCI · ECOG-ACRIN MEDICAL RESEARCH FOUNDATION · PI Peter J ODwyer, MITCHELL D. SCHNALL · fiscal years 2014 to 2026
  Named on NCT00602641
• Eastern Cooperative Oncology Group Operations Office
  U10CA021115 · NCI · FRONTIER SCI & TECHNOLOGY RSCH FDN, INC · PI ROBERT L COMIS · fiscal years 1985 to 2013
  Named on NCT00602641